Consensus Instil Bio, Inc.

Equities

TIL

US45783C2008

Market Closed - Nasdaq Other stock markets 21:30:00 26/04/2024 BST			5-day change	1st Jan Change
10.6 ^USD	+1.92%		-0.38%	+39.11%

04-26	Instil Bio, Inc. Announces Board Changes	CI
04-15	North American Morning Briefing : Stock Futures -2-	DJ

Evolution of the average Target Price on Instil Bio, Inc.

Price target over the last 5 years

History of analyst recommendation changes

ca6b0a.5eoboy1UU7KId-JcpBluFezhx-GPj3lM79wl9DPT7NU.iKBw4nw5MsPRDYAy4igjeJqXs9LbvQ44iK1OvX3lqp2uuGH2fQU0gM0e2g~c6e7eb0d81ae0ea59b664ddcb158207d

Analyst Recommendations on Instil Bio, Inc.

Jefferies Downgrades Instil Bio to Hold From Buy	04-12	MT
HC Wainwright Initiates Instil Bio With Buy Rating, $2 Price Target	29/06/23	MT
Truist Securities Reinstates Instil Bio at Hold	05/04/23	MT
Morgan Stanley Adjusts Instil Bio's Price Target to $2 From $6, Keeps Equalweight Rating	12/12/22	MT
Baird Lowers Price Target on Instil Bio to $14 From $24, Maintains Outperform Rating	17/11/22	MT
Morgan Stanley Adjusts Instil Bio Price Target to $6 From $8, Maintains Equal Weight Rating	01/11/22	MT
Baird Adjusts Instil Bio's Price Target to $24 From $31, Keeps Outperform Rating	01/11/22	MT
Cowen Downgrades Instil Bio to Market Perform From Outperform	01/11/22	MT
Baird Lowers Price Target on Instil Bio to $31 From $34, Maintains Outperform Rating	06/09/22	MT
Morgan Stanley Adjusts Instil Bio's Price Target to $8 From $9, Maintains Equalweight Rating	24/08/22	MT
Truist Securities Adjusts Instil Bio's Price Target to $16 from $25, Maintains Buy Rating	23/08/22	MT
Morgan Stanley Adjusts Instil Bio's Price Target to $9 From $14, Keeps Equalweight Rating	06/06/22	MT
Instil Bio Shares Drop 35% After FDA IND Clearance and Truist Price Target Cut	27/05/22	DJ
Morgan Stanley Adjusts Instil Bio Price Target to $14 From $15, Maintains Equal Weight Rating	24/05/22	MT
INSTIL BIO : Baird Starts Instil Bio at Outperform With $34 Price Target	13/08/21	MT
INSTIL BIO : Morgan Stanley Adjusts Instil Bio's Price Target to $23 From $24, Keeps Equal-Weight Rating	26/05/21	MT
INSTIL BIO : Jefferies Starts Instil Bio at Buy with $31 Price Target	13/04/21	MT
INSTIL BIO : Cowen Starts Instil Bio at Outperform	13/04/21	MT
INSTIL BIO : Morgan Stanley Initiates Coverage on Instil Bio With Equal-Weight Rating, $24 Price Target	13/04/21	MT
INSTIL BIO : Truist Securities Starts Instil Bio at Buy With $32 Price Target	13/04/21	MT